Skip to main content
HR 1703 115th Congress House Health Drug safety, medical device, and laboratory regulation Scientific communication

Medical Product Communications Act of 2017

Introduced: March 23, 2017 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 24, 2017
Referred to the Subcommittee on Health.
Mar 23, 2017
Referred to the House Committee on Energy and Commerce.
Mar 23, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Medical Product Communications Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to state that the intended use of a drug, biological product, or device shall be determined by the objective intent of the manufacturer and sponsor of such drug, biological product, or device, as demonstrated by statements contained in labeling, advertising, or analogous oral statements.

The intended use of these medical products shall not be determined by actual or constructive knowledge of the manufacturer or sponsor that these products will be used in a manner that varies from the use approved for marketing.

Additionally, the scientific exchange of information about these products shall not constitute labeling, advertising, or evidence of a new intended use. The bill sets forth the requirements for a scientific exchange.

What's happening now March 24, 2017

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1